We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TMCI market cap is 679.31M. The company's latest EPS is USD -0.8020 and P/E is -13.70.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 33.06M | 49.77M | 42.2M | 41.95M | 40.76M |
| Operating Income | -11.32M | -3.5M | -13.78M | -13.05M | -17.82M |
| Net Income | -12.13M | -4.41M | -13.45M | -12.27M | -17.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 39.42M | 57.37M | 94.42M | 141.84M | 187.12M |
| Operating Income | -3.54M | 855k | -16.51M | -34.84M | -51.43M |
| Net Income | -4.91M | -4.31M | -20.75M | -42.82M | -49.53M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 156.44M | 159.02M | 249.17M | 249.64M | 240.36M |
| Total Liabilities | 94.24M | 98.5M | 91.55M | 99.68M | 102.5M |
| Total Equity | 62.2M | 60.53M | 157.62M | 149.96M | 137.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 29.72M | 41.81M | 140.82M | 159.02M | 251.91M |
| Total Liabilities | 26.56M | 41.03M | 47.75M | 98.5M | 113.97M |
| Total Equity | 3.16M | 776k | 93.07M | 60.53M | 137.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.29M | -30.65M | -17.26M | -25.59M | -35.11M |
| Investing | -12.51M | -76.52M | -80.48M | -90.9M | -86.31M |
| Financing | 20.51M | 20.81M | 107.88M | 109.06M | 109.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.67M | -4.49M | -17.19M | -30.65M | -34.58M |
| Investing | -1.21M | -1.07M | -2.71M | -76.52M | -81.3M |
| Financing | 19.74M | 11.5M | 107.65M | 20.81M | 109.38M |
| Market Cap | 679.31M |
| Price to Earnings Ratio | -13.70 |
| Price to Sales Ratio | 3.63 |
| Price to Cash Ratio | 52.28 |
| Price to Book Ratio | 4.92 |
| Dividend Yield | - |
| Shares Outstanding | 61.76M |
| Average Volume (1 week) | 367.15k |
| Average Volume (1 Month) | 321.05k |
| 52 Week Change | -55.30% |
| 52 Week High | 27.70 |
| 52 Week Low | 5.27 |
| Spread (Intraday) | 2.83 (22.55%) |
| Company Name | Treace Medical Concepts Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.treace.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
